Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor

Kamilla Malinowska, Hannes Neuwirt, Ilaria T. Cavarretta, Jasmin Bektic, Hannes Steiner, Hermann Dietrich, Patrizia L. Moser, Dietmar Fuchs, Alfred Hobisch, Zoran Culig

Research output: Contribution to journalArticlepeer-review

Abstract

It is hypothesized that ligand-independent activation of the androgen receptor is one of the mechanisms implicated in tumour progression. However, supportive evidence is limited to the effect of HER-2/neu that stimulates prostate cancer progression through activation of the androgen receptor. In the present study, we have asked whether the proinflammatory cytokine interleukin-6 (IL-6), which is known to stimulate androgen receptor activity and expression of its downstream target genes, may also induce growth of androgen-sensitive cells. We have found that IL-6 differentially regulates proliferation of LAPC-4 and MDA PCa 2b cells. In MDA PCa 2b cells, growth stimulation by IL-6 was reversed by administration of either the non-steroidal anti-androgen bicalutamide or the inhibitor of the mitogen-activated protein kinase pathway PD98059. Neither cell line was found to express endogenous IL-6. Interestingly, the treatment of those prostate cancer cells did not increase phosphorylation of STAT3. The effect of IL-6 on stimulation of androgen receptor activity in MDA PCa 2b cells was lower than that of androgen, comparable with findings reported by other researchers. However, growth of MDA PCa 2b xenografts in castrated animals treated with IL-6 was similar to that in non-castrated animals. In addition, bicalutamide showed an inhibitory effect on IL-6-regulated growth in vivo. Taken together, data in the present study demonstrate that IL-6 may cause growth of androgen receptor-positive tumours in vitro and in vivo through activation of the androgen receptor.

Original languageEnglish
Pages (from-to)155-169
Number of pages15
JournalEndocrine-Related Cancer
Volume16
Issue number1
DOIs
Publication statusPublished - 2009

ASJC Scopus subject areas

  • Cancer Research
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Oncology

Fingerprint Dive into the research topics of 'Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor'. Together they form a unique fingerprint.

Cite this